Search This Blog

Thursday, August 29, 2019

Sandoz recalling Losartan and Ezetimibe over packaging issue

Bloomberg reports that Novartis (NVS +0.3%) unit Sandoz is recalling 636K bottles of Losartan Potassium and Ezetimibe due to packaging that does not meet requirements for child-resistance.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)